For the Quarter Ending September 2023
North America:

Throughout the third quarter of 2023, Carbamazepine API prices in North America mirrored the market trends observed in the APAC region. July saw prices remaining on the pessimistic side, but as Q3 progressed, there was a moderate rise in demand from the healthcare sector. Despite elevated Carbamazepine inventory levels in the local spot market, merchants aimed to meet arriving requirements. Moving into August, prices steadily increased, with manufacturers acquiring materials based on orders, ensuring a consistent Carbamazepine flow. However, surges in shipping costs and rising raw material (Acetic acid) prices deterred additional orders. The continuous increase in energy and fuel costs further contributed to the Carbamazepine price rise until the end of September.

Asia Pacific:

In the APAC region, especially in the Indian market, Carbamazepine API prices sustained a weaker trajectory in the first half of Q3 2023. This was driven by reduced consumption activity from end-user healthcare and pharmaceutical industries. Falling prices of raw materials, such as Acetic Acid, used in Carbamazepine production, contributed to price reductions. In August 2023, suppliers focused on replenishing inventories due to steadily increasing demand. Ongoing supply chain disruptions made it challenging for Indian pharmaceutical companies to import APIs, keeping prices high. The domestic acetic acid market also exhibited an upward trend, adding to the positive market trajectory. India's PMI numbers for August 2023 indicated continued growth in both the manufacturing and services sectors. Additionally, the September 2023 CPI in India showed relatively high inflation in recent months.

Get Real Time Prices of Carbamazepine: https://www.chemanalyst.com/Pricing-data/carbamazepine-1525

Europe:

In the German market, Carbamazepine prices mirrored the APAC region's trajectory during Q3 2023. July witnessed consistent price decreases, leading to higher inventories and weaker demand. Increased production of Carbamazepine API in exporting nations contributed to higher market supply, putting downward pressure on prices. However, August marked a rebound in pricing, stabilizing prices until the final weeks of September. High energy costs in Germany contributed to increased market prices, with buyers placing orders based on expected long-term growth. The decline in the euro's value against the US dollar made Carbamazepine API more expensive for eurozone buyers, further contributing to the September 2023 price rise.



About Us:

ChemAnalyst is an online platform offering a comprehensive range of market analysis and pricing services, as well as up-to-date news and deals from the chemical and petrochemical industry, globally.

Being awarded ‘The Product Innovator of the Year, 2023’, ChemAnalyst is an indispensable tool for navigating the risks of today's ever-changing chemicals market.

The platform helps companies strategize and formulate their chemical procurement by tracking real time prices of more than 400 chemicals in more than 25 countries.

ChemAnalyst also provides market analysis for more than 1000 chemical commodities covering multifaceted parameters including Production, Demand, Supply, Plant Operating Rate, Imports, Exports, and much more. The users will not only be able to analyse historical data but will also get to inspect detailed forecasts for upto 10 years. With access to local field teams, the company provides high-quality, reliable market analysis data for more than 40 countries.